The companies whose shares are moving in pre-market trade on Monday are: International Game Technology, Advanced Micro Devices, Micron Technology, Tesoro Corp, Pfizer, Netflix, FirstEnergy, Kimberly-Clark Corp, RadioShack and First Horizon National.
The top pre-market NASDAQ Stock Market gainers are: Tasty Baking, Global Crossing, American Medical Systems Holdings, RAM Energy Resources, and VIVUS. The top pre-market NASDAQ Stock Market losers are: Sina, Medivation, Energy Conversion Devices, JetBlue Airways, and Netflix.
Pfizer Inc. (NYSE: PFE) said it agreed to sell its Capsugel business, a maker of hard capsules, to private equity firm Kohlberg Kravis Robert & Co. for $2.375 billion in cash.
Pfizer Inc. (NYSE: PFE) said on Monday it has received a Refusal-to-File letter from the United States Food and Drug Administration (FDA) for tafamidis, the company’s oral investigational compound for patients with Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP).
Microsoft and federal agents took down Rustock, a botnet responsible at its peak for nearly half of the world's spam.
The companies whose shares are moving in pre-market trade on Monday are: Family Dollar Stores, Lorillard, Frontier Communications, Ameren, PNC Financial Services, MetLife, Novellus Systems, Novellus Systems, Marshall & Ilsley and Pfizer.
Biogen Idec stock price can appreciate to the mid $70s based on five areas of potential upside, according to RBC Capital Markets. The brokerage upgraded its rating on shares of the biotechnology company to outperform from sector perform and increased its price target to $75 from $60.
Pfizer Inc said it has settled all outstanding lawsuits involving accusations that it tested the experimental antibiotic Trovan on children in Nigeria during a 1996 meningitis outbreak without receiving adequate prior consent.
A new virtual entrepreneurship hub from the New York University will now enable technology innovation and startup formation within the campus community by providing a growing array of entrepreneurial resources, programs, and activities online.
US stocks extend gains in early trade on Tuesday after a report showed that manufacturing activity rose at a faster pace than expected in January.
Pfizer Inc. (NYSE: PFE) will close its research and development (R&D) facility in Sandwich, Kent, England, which presently employs 2,400 people, the “majority” of which would be made redundant over the next two years.
The companies which are expected to see active trade on Tuesday are: BP, Pfizer, C.H. Robinson, Emerson, United Parcel, McGraw Hill Companies, Lexmark International and Cummins.
Earnings reports and acquisition announcements took a back seat to the violent unrest in Egypt today, as U.S. stocks fall.
U.S. generic drug maker Mylan Inc has settled two U.S. patent disputes with global pharma giant Pfizer Inc, which will enable the former to sell the generic versions of cholesterol drug Lipitor and combination blood pressure and cholesterol treatment Caduet.
Indian pharmaceutical company Dr Reddy's Laboratories Ltd on Thursday said it has launched a generic version of Protonix, a drug used to control the amount of acid in the stomach, in the United States.
While Chinese President Hu Jintao is being entertained by U.S. President Barack Obama, and the U.S. House of Representatives votes to repeal the Obama administration’s healthcare reform law, both U.S. healthcare and Sino-American relations are the main components today of a less highly publicized event.
Scientists have found a protein that acts as a master switch to determine whether certain white blood cells will boost or dampen inflammation, a finding that may help the search for new drugs for rheumatoid arthritis.
World’s largest drug maker Pfizer has moved the court against Dr Reddy’s Laboratories seeking a delay in launching the Indian drug maker’s low-cost version of atorvastatin, the world’s best-selling medicine, in the US market.
Pfizer (NYSEL PFE) has recalled about 19,000 bottles of its Lipitor tablets after an “uncharacteristic odor” was reported in a bottle of the blockbuster cholesterol drug
Swiss drug maker Novartis will pay $12.9 billion to buy the remaining shares of Alcon it doesn't already own to broaden its presence in the booming eye-care market, which is expected to outgrow the pharmaceuticals market in coming years.
U.S. drug giant Pfizer (NYSE: PFE) hired investigators to dig up dirt on Nigeria’s former attorney general in order to stop an investigation over a controversial drug trial the company conducted which led to the deaths of eleven children, according to cables released by WikiLeaks.
Futures on the S&P 500 are down 0.30 percent to 1,219.80, futures on the Dow Jones Industrial Average are down 0.21 percent to 11,340.00 and Nasdaq100 futures are down 0.19 percent to 2,183.00.